The Food and Drug Administration (FDA) announces that the telephone numbers for the Center for Device Regulation, Radiation Health, and Research (CDRRHR) are suspended from March 4, 2025, to March 28, 2025, or until the completion of necessary roofing installation at their facilities.
Alternative Contact Methods
During this period, stakeholders and the public are advised to use alternative email communication to reach CDRRHR refer to the emails listed below:
| Office | Concern | |
| Licensing and Registration Division | cdrrhr.lrd@fda.gov.ph | Medical and Health related devices/establishment queries and follow-ups |
| Product Research and Standards Development Division | cdrrhr-prsdd@fda.gov.ph | Adverse event reporting, field safety corrective action report, product complaint, request for product and establishment verification involving medical and health- related devices. |
| Radiation regulation Division | cdrrhr.rrd@fda.gov.ph | Radiation-related queries, follow-ups of application and submission of compliance documents of radiation facilities. |
Continued Operations
- Despite the suspension of telephone services, CDRRHR will continue normal operations.
- Stakeholders are encouraged to direct all urgent concerns, inquiries, follow-ups, and complaints to the appropriate email address.
- Response times may be delayed due to the change in communication channels.
Next Steps
For official updates, refer to FDA-Advisory-No.2025-0188.pdf
If you have questions or need help, contact us at sales@andamanmed.com or click the button below.
Register your medical device in the Philippines
